Skip to main content
. Author manuscript; available in PMC: 2013 Mar 15.
Published in final edited form as: Leukemia. 2011 Sep 9;26(3):443–450. doi: 10.1038/leu.2011.246

Figure 2.

Figure 2

MRx102 decreases XIAP and Mcl-1 protein levels and inhibits RNA synthesis. OCI-AML3 cells were treated with MRx102 and triptolide. (A) XIAP and Mcl-1 protein levels were determined at 24 hours by western blot analysis, and (B) RNA synthesis was assessed at 4 hours and 24 hours by quantitating uridine incorporation.

HHS Vulnerability Disclosure